Eyebiotech Limited
13503296
Some Concerns
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
full
Next accounts due
30/09/2026
Confirmation statement
Last: 08/07/2025
Due 22/07/2026
Industry
Officers
director · Since 11/07/2024
MANAGING DIRECTOR PHARMACEUTICALS
BRITISH · UNITED KINGDOM · Age 51
Also on 8 other boards
director · Since 11/07/2024
CHARTERED ACCOUNTANT
BRITISH · UNITED KINGDOM · Age 58
Also on 4 other boards
Peter James O'Shaughnessy
director · Since 01/07/2026
BRITISH · UNITED KINGDOM · Age 56
Former
director · Resigned 01/07/2026
Persons with Significant Control
Merck & Co., Inc.
126, E. Lincoln Avenue, Rahway, 07065-4646
Reg: 7954610000 · New York Stock Exchange · Corporation
Notified 11/07/2024
Former PSCs
Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp
Ceased 03/02/2022
Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp
Ceased 13/10/2023